Q32 Bio Inc. Balance Sheet
QTTB|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Q32 Bio Inc. had $62M in total assets and $6M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48.3M | $78.0M | $39.3M | $34.0M | $108.4M | $217.4M | $53.8M | $38.2M |
| Current Assets | $55.0M | $81.9M | $83.9M | $181.0M | $191.9M | $219.6M | $266.6M | $221.7M |
| PP&E (Net) | $979.0K | $1.4M | $0 | $1.1M | $2.3M | $37.0M | $42.7M | $35.6M |
| Total Assets | $61.8M | $92.3M | $84.6M | $228.5M | $211.7M | $263.7M | $310.6M | $259.1M |
| Current Liabilities | $11.3M | $16.5M | $11.6M | $22.6M | $17.2M | $22.7M | $12.4M | $25.4M |
| Shareholders' Equity | $5.7M | -$182.9M | $178.0M | $169.7M | $196.0M | $258.5M | $196.4M | -$39.5M |